Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-369,425
Closed -$10.7M 19
2016
Q4
$10.7M Hold
369,425
5.28% 8
2016
Q3
$10.1M Hold
369,425
5.29% 7
2016
Q2
$8.06M Hold
369,425
4.72% 11
2016
Q1
$8.25M Hold
369,425
4.59% 12
2015
Q4
$10.2M Hold
369,425
5.35% 8
2015
Q3
$9.53M Hold
369,425
5.31% 10
2015
Q2
$9.16M Hold
369,425
4.86% 11
2015
Q1
$9.31M Hold
369,425
5.14% 10
2014
Q4
$8.67M Hold
369,425
5.66% 10
2014
Q3
$8.41M Hold
369,425
5.92% 9
2014
Q2
$9.03M Hold
369,425
6.36% 9
2014
Q1
$7.79M Buy
+369,425
New +$7.79M 5.76% 8

Other funds holding QGENF

Tikvah Management's QGENF Position: Q1 2017 in Review

Tikvah Management sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 369,425 shares — an estimated $10.7M sold.

Tikvah Management first reported a position in QGENF in Q1 2014 and held it in 12 quarters. The position peaked at $10.7M in Q4 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Tikvah Management reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Tikvah Management sold 369,425 QIAGEN NV shares in Q1 2017, an estimated $10.7M.
  • Tikvah Management first reported a position in QIAGEN NV in Q1 2014 and held it in 12 quarters.
  • Tikvah Management's QIAGEN NV position peaked at $10.7M in Q4 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Tikvah Management's 13F filing for Q1 2017, filed 12 May 2017.